%0 Journal Article
%A Plaza, Vicente
%A Alobid, Isam
%A Alvarez, Cesáreo
%A Blanco, Marina
%A Ferreira, Jorge
%A García, Gabriel
%A Gómez-Outes, Antonio
%A Gómez, Fernando
%A Hidalgo, Antonio
%A Korta, Javier
%A Molina, Jesús
%A Pellegrini, Francisco Javier
%A Pérez, Montserrat
%A Plaza, Javier
%A Praena, Manuel
%A Quirce, Santiago
%A Sanz, José
%T Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.
%D 2021
%U http://hdl.handle.net/10668/21988
%X In this fifth phase of development, the contents of the Spanish Asthma Management Guidelines (GEMA), which include versions 5.0 and 5.1, have undergone a thorough review. The aim here is to set the main changes in context. These could be summarized as follows: DIAGNOSIS: new FENO cut-off and severity classification based on treatment needed to maintain control; INTERMITTENT ASTHMA: a more restrictive concept and treatment extended to include a glucocorticoid/adrenergic combination as needed; MILD ASTHMA: glucocorticoid/adrenergic therapy as needed as an alternative in case of low therapeutic adherence to conventional fixed-dose steroids; SEVERE ASTHMA: readjustment of phenotypes, incorporation of triple therapy in a single inhaler, and criteria for selection of a biologic in severe uncontrolled asthma; OTHERS: specific scoring in childhood asthma, incorporation of certain organizational aspects (care circuits, asthma units, telemedicine), new sections on COVID-19 and nasal polyposis.
%K Asma
%K Asthma
%K Clinical practice guidelines
%K Consenso
%K Consensus
%K Evidence-based medicine
%K Guía de práctica clínica
%K Medicina basada en la evidencia
%~